Validated stability indicating HPLC method for estimation of theophylline from a novel microsphere formulation
Main Article Content
Abstract
chromatographic (HPLC) method was developed and validated for determination of theophylline from a novel
formulation. The liquid chromatographic separation was achieved isocratically using a mobile phase of acetonitrile: 50 mM
sodium acetate buffer (15:85) adjusted to pH 6.5 using dilute hydrochloric acid. The analysis was carried out using Hi-Q-Sil
C18 column [250 mm x 4.6 mm, 5 μm] at flow rate of 1 ml/min and the UV detection at 270 nm. The method was validated
for accuracy, precision, linearity, range, selectivity, and robustness. The linearity of the proposed method was investigated
in the range of 1 to 24 μg/ml (r2 = 0.9995). The drug was subjected to oxidation, hydrolysis, heat, and photolysis to apply
stress conditions. The method provided good peak parameters with retention time of 8.6 ± 0.3 min. Degradation products
resulting from stress studies did not interfere with the detection of theophylline and the assay can thus be considered as
stability-indicating.
Downloads
Article Details
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.
References
Pather SI, Russell I, Syce JA, Neau SH. Sustained release theophylline
tablets by direct compression - Part 1: Formulation and in vitro testing.
Int J Pharm 1998;164:1-10.
Amol P, Sanjay B, Vijay J, Deepak S. Sustained release tablet of
theophylline by hot melt wax coating technology. Asian J Pharma
;2:26-9.
Zheng W, Cerea M, Sauer D, McGinity JW. Properties of theophylline
tablets powder-coated with methacrylate ester copolymers. STP Pharma
Sci p. 1157-489.
Lorenzo R and Maurizio C. Evaluation of theophylline tablets compacted
by means of a novel ultrasound-assisted apparatus. Int J Pharm
;170:201-8.
Mutasem G. Comparative bioavailability of two test brands of
theophylline - Tablets and a reference, Quibron® under fasting and
Limited food conditions. Med J Isl Acad Sci 2000;13:109-14.
Sanghavi NM, Kamath PR, Amin DS. Sustained Release Tablets of
Theophylline. Drug Dev Ind Pharm 1990;16:1843-8.
Evelyn O, Edna M, Tais C, Vladi O. Formulation and in vitro evaluation
of theophylline-Eudragit® sustained-release tablets. Braz J Pharm Sci
;41:377-84.
Meshali MM. Preparation and evaluation of theophylline sustainedrelease
tablets. Drug Dev Ind Pharm 1996;22:373-6.
Nakano M, Ohmori N, Ogata A, Sugimoto K, Tobino Y, Iwaoku R, et al.
Sustained release of theophylline from hydroxypropylcellulose tablets.
J Pharm Sci 1983;72:378-80.
United State Pharmacopoeia, USP 27, 1181-2.
Lunn G. HPLC Methods for Pharmaceutical Analysis. Vol 4. Wiley
Interscience Publication; p. 1268-73.
Lunn G, Schmuff N. HPLC Methods for Pharmaceutical Analysis. Vol 4.
Wiley Interscience Publication; p. 1359-61.
Hotchkiss SA, Caldwell J. High-performance liquid chromatographic
assay for theophylline and its major metabolites in human urine. J
Chromatogr 1987;423:179-88.
Kawakatsu K, Nishimura K, Kawai M, Chikuma M. Separation and
determination of theophylline from paraxanthine in human serum by
reversed-phase high-performance liquid chromatography. J Pharm Bio
Anal 1989;7:965-73.
Nirogi RV, Kandikere VN, Shukla M, Mudigonda K, Ajjala DR. A simple
and rapid HPLC/UV method for the simultaneous quantification of
theophylline and etofylline in human plasma. J Chromat B Analyt
Technol Biomed Life Sci 2007;848:271-6.
Text on Validation of analytical procedures, international conference
on harmonization, September 1993.
Proceedings of the International Conference on Harmonization of
Technical Requirements of Registration of Pharmaceuticals for Human
Use (ICH Harmonized Tripartite Guidelines). Validation of Analytical
Procedures: Methodology, ICH-Q2B, Geneva, 1996.
Q2 (R1) ICH guidelines, Validation of Analytical Procedures: Text and
Methodology.
Proceedings of the International Conference on Harmonization of
Technical Requirements of Registration of Pharmaceuticals for Human
Use. Validation of Analytical Procedures, ICH-Q2A, Geneva, 1995
United States Pharmacopoeia 28, National Formulary 23.Validation of
Compendial Methods, Rockville: U.S. Pharmacopoeial Convention Inc;
p. 2748-51. (General Chapter 1225).
Center for Drug Evaluation and Research, Reviewers Guidance,
Validation of Chromatographic Methods, 1994.
John H. Method Validation in Pharmaceutical Analysis. Wiley
Publication; p. 195-211.
Joseph S. Practical HPLC Method Development. 2 ed. Wiley Interscience
Publication; 684-705.
Anuja. HPLC Method Development for pharmaceuticals. Vol 8. Elsevier
Publication; p. 441- 9.
Baboota S. Development and validation of a stability-indicating HPLC
method for analysis of celecoxib (CXB) in bulk drug and micro emulsion
formulations. Act Chromato 2007;18:116-29.
Chaibva FA, Walker RB. Development and validation of a stabilityindicating
analytical method for the quantitation of oxytocin in
pharmaceutical dosage forms. J Pharm Biomed Anal 2007;43:179-85.
Mohammadi A, Mehramizi A, Moghaddam FA, Jabarian LE, Pourfarzib
M, Kashani HN. Development and validation of a stability-indicating
high performance liquid chromatographic (HPLC) assay for biperiden
in bulk form and pharmaceutical dosage forms. J Chromatogr B Analyt
Technol Biomed Life Sci 2007;854:152-7.
Mohammadi A, Haririan I, Rezanour N, Ghiasi L, Walker RB. A
stability-indicating high performance liquid chromatographic
assay for the determination of orlistat in capsules. J Chromatogr A
;1116:153-7.